76 related articles for article (PubMed ID: 23868328)
1. Selective inhibition of mucosal serotonin as treatment for IBD?
Levin AD; van den Brink GR
Gut; 2014 Jun; 63(6):866-7. PubMed ID: 23868328
[No Abstract] [Full Text] [Related]
2. Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.
Margolis KG; Stevanovic K; Li Z; Yang QM; Oravecz T; Zambrowicz B; Jhaver KG; Diacou A; Gershon MD
Gut; 2014 Jun; 63(6):928-37. PubMed ID: 23749550
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
[TBL] [Abstract][Full Text] [Related]
4. Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment.
Arijs I; De Hertogh G; Machiels K; Van Steen K; Lemaire K; Schraenen A; Van Lommel L; Quintens R; Van Assche G; Vermeire S; Schuit F; Rutgeerts P
Am J Gastroenterol; 2011 Apr; 106(4):748-61. PubMed ID: 21326222
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
6. Enteric serotonin and oxytocin: endogenous regulation of severity in a murine model of necrotizing enterocolitis.
Gross Margolis K; Vittorio J; Talavera M; Gluck K; Li Z; Iuga A; Stevanovic K; Saurman V; Israelyan N; Welch MG; Gershon MD
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G386-G398. PubMed ID: 28774871
[TBL] [Abstract][Full Text] [Related]
7. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis.
Linden DR; Chen JX; Gershon MD; Sharkey KA; Mawe GM
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G207-16. PubMed ID: 12646422
[TBL] [Abstract][Full Text] [Related]
8. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis.
Linden DR; Foley KF; McQuoid C; Simpson J; Sharkey KA; Mawe GM
Neurogastroenterol Motil; 2005 Aug; 17(4):565-74. PubMed ID: 16078946
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Epithelial Cell-specific Deletion of α-Mannosidase II Ameliorates Experimental Colitis.
Suzuki K; Yamada T; Yamazaki K; Hirota M; Ishihara N; Sakamoto M; Takahashi D; Iijima H; Hase K
Cell Struct Funct; 2018 Mar; 43(1):25-39. PubMed ID: 29343654
[TBL] [Abstract][Full Text] [Related]
11. Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis.
Lee M; Kovacs-Nolan J; Yang C; Archbold T; Fan MZ; Mine Y
J Agric Food Chem; 2009 Mar; 57(6):2233-40. PubMed ID: 19231858
[TBL] [Abstract][Full Text] [Related]
12. IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.
Scheibe K; Backert I; Wirtz S; Hueber A; Schett G; Vieth M; Probst HC; Bopp T; Neurath MF; Neufert C
Gut; 2017 May; 66(5):823-838. PubMed ID: 26783184
[TBL] [Abstract][Full Text] [Related]
13. Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats.
El-Salhy M; Hatlebakk JG
Mol Med Rep; 2016 Dec; 14(6):4967-4974. PubMed ID: 27840918
[TBL] [Abstract][Full Text] [Related]
14. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.
Spohn SN; Bianco F; Scott RB; Keenan CM; Linton AA; O'Neill CH; Bonora E; Dicay M; Lavoie B; Wilcox RL; MacNaughton WK; De Giorgio R; Sharkey KA; Mawe GM
Gastroenterology; 2016 Nov; 151(5):933-944.e3. PubMed ID: 27480173
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.
Sun M; He C; Wu W; Zhou G; Liu F; Cong Y; Liu Z
Clin Exp Immunol; 2017 Mar; 187(3):428-440. PubMed ID: 27921309
[TBL] [Abstract][Full Text] [Related]
16. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
17. Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease.
Zhou G; Yu L; Yang W; Wu W; Fang L; Liu Z
Mediators Inflamm; 2016; 2016():2543070. PubMed ID: 27721573
[No Abstract] [Full Text] [Related]
18. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
Terc J; Hansen A; Alston L; Hirota SA
Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli.
Spisni E; Valerii MC; De Fazio L; Cavazza E; Borsetti F; Sgromo A; Candela M; Centanni M; Rizello F; Strillacci A
Mol Ther; 2015 Feb; 23(2):278-89. PubMed ID: 25393372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
